PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2014

PHARMANIAGA BERHAD

Financial Year End

31/12/2014
Quarter2
Quarterly report for the financial period ended30/06/2014
The figureshave not been audited

Attachments

PHARMA 0614.pdf
235 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2014

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2014
30/06/2013
30/06/2014
30/06/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
525,072
437,633
993,744
937,972
2Profit/(loss) before tax
24,622
9,605
62,781
46,529
3Profit/(loss) for the period
15,957
6,171
42,603
31,324
4Profit/(loss) attributable to ordinary equity holders of the parent
15,975
5,865
42,192
30,636
5Basic earnings/(loss) per share (Subunit)
6.17
2.27
16.30
11.83
6Proposed/Declared dividend per share (Subunit)
4.00
3.41
8.00
6.82


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9400
1.8800
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced21 Aug 2014  
CategoryFinancial Results
Reference NoPB-140807-6F27B